Payers responding to CompPharma’s 12th Annual Survey of Prescription Drug Management in Workers’ Compensation reported an increase of 6.4 percent in their 2014 drug spending, the first increase since 2009, when payers reported an increase of 9.4 percent. Long term opioid use was the chief concern among respondents, with some citing physician-dispensing of opioids and related drugs and continuing FDA approvals of new abuse-deterrent narcotics as a corollary to the issue. Payers explained that abuse-deterrent mechanisms are often easily bypassed and that addiction and abuse remain significant. Workers’ comp pharmacy spending is between $5 billion and $7 billion annually.
Read more from Workers’ Compensation Institute 360 here.